| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0009 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |